Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2026-01-28 @ 3:30 PM
Study NCT ID:
NCT02317159
Status:
UNKNOWN
Last Update Posted:
2014-12-15
First Post:
2014-12-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia
Sponsor:
Organization: